Altimmune And UAB Announce Publication Of Compelling Pre-Clinical Data For AdCOVID ™ Intranasal COVID-19 Vaccine Candidate

GAITHERSBURG, Md., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today pre-published a comprehensive preclinical evaluation of its single-dose, intranasal COVID-19...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials